Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Phase 3 Izokibep Study in HS Produces Promising Results
AMSTERDAM — The investigational interleukin (IL)-17A inhibitor izokibep induces clear clinical responses in people with moderate to severe hidradenitis suppurativa (HS) within a few weeks of treatment, according to the results of a randomized controlled phase 3 trial presented at…
English